182 related articles for article (PubMed ID: 16255047)
1. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome.
Saito M; Fujisawa A; Nishikomori R; Kambe N; Nakata-Hizume M; Yoshimoto M; Ohmori K; Okafuji I; Yoshioka T; Kusunoki T; Miyachi Y; Heike T; Nakahata T
Arthritis Rheum; 2005 Nov; 52(11):3579-85. PubMed ID: 16255047
[TBL] [Abstract][Full Text] [Related]
2. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
[TBL] [Abstract][Full Text] [Related]
3. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
[TBL] [Abstract][Full Text] [Related]
4. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A
Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411
[TBL] [Abstract][Full Text] [Related]
5. Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment.
Rösen-Wolff A; Quietzsch J; Schröder H; Lehmann R; Gahr M; Roesler J
Eur J Haematol; 2003 Sep; 71(3):215-9. PubMed ID: 12930324
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
[TBL] [Abstract][Full Text] [Related]
7. Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome.
Hentgen V; Despert V; Leprêtre AC; Cuisset L; Chevrant-Breton J; Jégo P; Chalès G; Gall EL; Delpech M; Grateau G
J Rheumatol; 2005 Apr; 32(4):747-51. PubMed ID: 15801036
[TBL] [Abstract][Full Text] [Related]
8. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
[TBL] [Abstract][Full Text] [Related]
9. Enhanced interleukin-1beta and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome.
Janssen R; Verhard E; Lankester A; Ten Cate R; van Dissel JT
Arthritis Rheum; 2004 Oct; 50(10):3329-33. PubMed ID: 15476236
[TBL] [Abstract][Full Text] [Related]
10. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes.
Feldmann J; Prieur AM; Quartier P; Berquin P; Certain S; Cortis E; Teillac-Hamel D; Fischer A; de Saint Basile G
Am J Hum Genet; 2002 Jul; 71(1):198-203. PubMed ID: 12032915
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene.
Aróstegui JI; Aldea A; Modesto C; Rua MJ; Argüelles F; González-Enseñat MA; Ramos E; Rius J; Plaza S; Vives J; Yagüe J
Arthritis Rheum; 2004 Dec; 50(12):4045-50. PubMed ID: 15593220
[TBL] [Abstract][Full Text] [Related]
12. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
[No Abstract] [Full Text] [Related]
13. Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients.
Saito M; Nishikomori R; Kambe N; Fujisawa A; Tanizaki H; Takeichi K; Imagawa T; Iehara T; Takada H; Matsubayashi T; Tanaka H; Kawashima H; Kawakami K; Kagami S; Okafuji I; Yoshioka T; Adachi S; Heike T; Miyachi Y; Nakahata T
Blood; 2008 Feb; 111(4):2132-41. PubMed ID: 18063752
[TBL] [Abstract][Full Text] [Related]
14. A novel missense mutation in CIAS1 encoding the pyrin-like protein, cryopyrin, causes familial cold autoinflammatory syndrome in a family of Ethiopian origin.
Shalev SA; Sprecher E; Indelman M; Hujirat Y; Bergman R; Rottem M
Int Arch Allergy Immunol; 2007; 143(3):190-3. PubMed ID: 17284928
[TBL] [Abstract][Full Text] [Related]
15. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes.
Maksimovic L; Stirnemann J; Caux F; Ravet N; Rouaghe S; Cuisset L; Letellier E; Grateau G; Morin AS; Fain O
Rheumatology (Oxford); 2008 Mar; 47(3):309-10. PubMed ID: 18174231
[TBL] [Abstract][Full Text] [Related]
16. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene.
Matsubayashi T; Sugiura H; Arai T; Oh-Ishi T; Inamo Y
Acta Paediatr; 2006 Feb; 95(2):246-9. PubMed ID: 16449034
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.
Hawkins PN; Lachmann HJ; Aganna E; McDermott MF
Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505
[TBL] [Abstract][Full Text] [Related]
18. High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study.
Tanaka N; Izawa K; Saito MK; Sakuma M; Oshima K; Ohara O; Nishikomori R; Morimoto T; Kambe N; Goldbach-Mansky R; Aksentijevich I; de Saint Basile G; Neven B; van Gijn M; Frenkel J; Aróstegui JI; Yagüe J; Merino R; Ibañez M; Pontillo A; Takada H; Imagawa T; Kawai T; Yasumi T; Nakahata T; Heike T
Arthritis Rheum; 2011 Nov; 63(11):3625-32. PubMed ID: 21702021
[TBL] [Abstract][Full Text] [Related]
19. CIAS1 mutation in a patient with overlap between Muckle-Wells and chronic infantile neurological cutaneous and articular syndromes.
Granel B; Philip N; Serratrice J; Ene N; Grateau G; Dodé C; Cuisset L; Disdier P; Berbis P; Delpech M; Weiller PJ
Dermatology; 2003; 206(3):257-9. PubMed ID: 12673085
[TBL] [Abstract][Full Text] [Related]
20. Detection of a novel mutation in NLRP3/CIAS1 gene in an Indian child with Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
Nair SB; Chavan PP; Athalye AS; Aksentijevich I; Khubchandani RP
Clin Rheumatol; 2019 Feb; 38(2):403-406. PubMed ID: 30066283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
